Sign In
Buy XGN
$4.54
-0.280 (-5.81%)
At Close: Jun 03, 2026
Exagen Inc. to Participate in the Canaccord Genuity 44th Annual Growth Conference
09:00am, Friday, 02'nd Aug 2024
CARLSBAD, Calif., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the Canaccord Genuity 44th Annu
Exagen Appoints Jeffrey G. Black as New Chief Financial Officer
09:00am, Thursday, 01'st Aug 2024
CARLSBAD, Calif., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions announced today the appointment of Jeffrey G. Black, to the role of Ch
Exagen to Announce Second Quarter 2024 Results on August 5, 2024
09:00am, Monday, 22'nd Jul 2024
CARLSBAD, Calif., July 22, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, will release financial results for the quarter ended June 30, 2024, before the
Why Fast-paced Mover Exagen (XGN) Is a Great Choice for Value Investors
10:34am, Thursday, 13'th Jun 2024
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Exagen (XGN) could be a great choice. It is one of the several stocks that passed th
Time to Play 5 Top-Ranked Stocks With Rising P/E?
01:14pm, Monday, 10'th Jun 2024
Wall Street has been hovering around a record high level, which can trigger overvaluation concerns in some investors' minds. This is because investors often opt for the stock-picking approach that inv
Time to Play 5 Top-Ranked Stocks With Rising P/E?
09:05am, Monday, 10'th Jun 2024
Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks include AMC Entertainment (AMC), Exagen (XGN), Health Catalyst (HCAT), CLEAR Secure (YOU) and Applied DNA
Exagen, Inc. (XGN) Q1 2024 Earnings Call Transcript
11:25am, Monday, 13'th May 2024
Exagen, Inc. (NASDAQ:XGN ) Q1 2024 Earnings Conference Call May 13, 2024 8:30 AM ET Company Participants Ryan Douglas - Investor Relations John Aballi - President and Chief Executive Officer Kamal Ada
Exagen Inc. (XGN) Reports Q1 Loss, Tops Revenue Estimates
10:10am, Monday, 13'th May 2024
Exagen Inc. (XGN) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.40. This compares to loss of $0.44 per share a year ago.
Exagen Inc. Reports Strong First Quarter 2024 Results: Raises Guidance for Full Year
08:00am, Monday, 13'th May 2024
CARLSBAD, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended March 31, 2024
Exagen to Announce First Quarter 2024 Results on May 13, 2024
04:05pm, Tuesday, 30'th Apr 2024
CARLSBAD, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, will release financial results for the quarter ended March 31, 2024, before th
Exagen Inc. Announces Changes to the Board of Directors
08:30am, Friday, 26'th Apr 2024
CARLSBAD, Calif., April 26, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced changes to the Board of Directors.
Exagen Inc. (XGN) Q4 2023 Earnings Call Transcript
01:23pm, Monday, 18'th Mar 2024
Exagen Inc. (XGN) Q4 2023 Earnings Call Transcript
Exagen Inc. (XGN) Reports Q4 Loss, Tops Revenue Estimates
10:25am, Monday, 18'th Mar 2024
Exagen Inc. (XGN) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a loss of $0.41. This compares to loss of $0.58 per share a year ago.
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 Results
08:00am, Monday, 18'th Mar 2024
CARLSBAD, Calif., March 18, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the fourth quarter and full ye
Exagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
09:00am, Friday, 08'th Mar 2024
CARLSBAD, Calif., March 08, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the KeyBanc Capital Markets Li
